MedTrace Logo

Acceptability of Folic Acid and Vitamin B12 Fortified Meals

NCT06094049 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 72

Last updated 2024-05-08

No results posted yet for this study

Summary

Evaluation of sensory acceptability of fortified products prior to distribution is essential. We aim to evaluate whether fortification affects sensory qualities and whether these are acceptable to rural communities. Standard meals will be prepared using unfortified and fortified-flour with folic acid and vitamin B12. Preference and triangle tests will be conducted among women residing in rural areas of Ethiopia.

Conditions

  • Dietary Habits

Interventions

OTHER

Preference test group

Standard meals will be prepared including the commonly consumed porridge and/or bread using flour fortified with folic acid and vitamin B12. The meals will be prepared in the same way, by a local person who is familiar with the selected food.

OTHER

Triangle test group

Standard meals will be prepared including the commonly consumed porridge and/or bread using unfortified flour and fortified-flour with folic acid and vitamin B12. The meals will be prepared in the same way, by a local person who is familiar with the selected food and who will be blinded to the flour type.

Sponsors & Collaborators

  • Arba Minch University

    collaborator OTHER

  • Institut de Recherche en Sciences de la Sante, Burkina Faso

    collaborator OTHER_GOV

  • Addis Ababa University

    collaborator OTHER

  • University Ghent

    lead OTHER

Principal Investigators

  • Stefaan De Henauw, MD, PHD · University Ghent

Eligibility

Min Age
15 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-06
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • Ethiopia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06094049 on ClinicalTrials.gov